Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial
Year: 2026
Type: article
Study design: Clinical Trial
Authors: Carolyn Bolton Moore, Kristin Baltrusaitis, Edmund V Capparelli, Elizabeth D Lowenthal, Dwight E Yin, John H Moye, Christiana Smith, Michael Whitton, Conn M Harrington, Herta Crauwels, Rodica Van Solingen-Ristea, Mark A Marzinke, Barbara Heckman, Andi Ace, Shawn Ward, Kyle Whitson, Jenny Huang, S Y Amy Cheung, Brookie M Best, Ellen Townley, Allison Agwu, Pradthana Ounchanum, Sisinyana Ruth Mathiba, Linda Aurpibul, Violet Korutaro, Gaerolwe Masheto, Faeezah Patel, Evette Moodley, Aditya H Gaur, Avy Violari, Maxensia Owor, Kulkanya Chokephaibulkit, Andres Camacho-Gonzalez, Mary Paul, Samantha Fry, Jennifer Jao, Charles Mitchell, Sara Zabih, Veerle Van Eygen, Kati Vandermeulen, Ann Buchanan, Yu-Wei Lin, Kelong Han, Jon Collins, Chelsea Stotz, Rachel Scheckter, Sarah Buisson
Institutions: Centre for Infectious Disease Research in Zambia, University of Alabama at Birmingham, Harvard University, University of California San Diego, Children's Hospital of Philadelphia, University of Pennsylvania, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, University of Colorado Anschutz, Family Health International 360, Johns Hopkins University, Frontier Science & Technology Research Foundation, Inc., GlaxoSmithKline (Canada), GlaxoSmithKline (United States), ChiangRai Prachanukroh Hospital, University of the Witwatersrand, Perinatal HIV Research Unit, Chiang Mai University, Baylor College of Medicine Children’s Foundation, Centre for the AIDS Programme of Research in South Africa, St. Jude Children's Research Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7220666296
